Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop
Regulation (EU) No 536/2014 (Clinical Trial Regulation, CTR) offers two precious tools to academic clinical research in Italy:- The right to transfer not-for-profit clinical trials data and results for registration purposes, and co-sponsorship.- The right to transfer data reduces the time needed to...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865422001090 |
_version_ | 1798001159457210368 |
---|---|
author | Alessandra Mancino Enrico Crea Monica Messina Marco Ferrante Maria Valeria Feraco Paola Fazi Marco Vignetti |
author_facet | Alessandra Mancino Enrico Crea Monica Messina Marco Ferrante Maria Valeria Feraco Paola Fazi Marco Vignetti |
author_sort | Alessandra Mancino |
collection | DOAJ |
description | Regulation (EU) No 536/2014 (Clinical Trial Regulation, CTR) offers two precious tools to academic clinical research in Italy:- The right to transfer not-for-profit clinical trials data and results for registration purposes, and co-sponsorship.- The right to transfer data reduces the time needed to make innovative therapeutical agents and therapies accessible to the patient.Co-sponsorship, on the other hand, allows the establishment of a partnership between entities with different missions, ideals and attitudes, sharing – nevertheless - the same ultimate goal: meeting the patient's medical needs. Co-sponsorship facilitates collaboration among experts, which allows knowledge sharing, thus guaranteeing, to each contributor, recognition for their own contributions to a complex activity such as a clinical trial.However, the above-mentioned Regulation poses important challenges, especially in terms of infrastructural efficiency, which is demanding, especially for those entities suffering organizational inadequacies: unfortunately, inefficiency is sometimes a structural problem in the academic clinical environment. This publication focuses on the specific innovative aspects introduced by CTR. It also highlights the possible difficulties to be addressed by their implementation. |
first_indexed | 2024-04-11T11:31:41Z |
format | Article |
id | doaj.art-8fb236c3cd414d18a76a85ceb82be01a |
institution | Directory Open Access Journal |
issn | 2451-8654 |
language | English |
last_indexed | 2024-04-11T11:31:41Z |
publishDate | 2022-10-01 |
publisher | Elsevier |
record_format | Article |
series | Contemporary Clinical Trials Communications |
spelling | doaj.art-8fb236c3cd414d18a76a85ceb82be01a2022-12-22T04:26:06ZengElsevierContemporary Clinical Trials Communications2451-86542022-10-0129100992Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loopAlessandra Mancino0Enrico Crea1Monica Messina2Marco Ferrante3Maria Valeria Feraco4Paola Fazi5Marco Vignetti6Fondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, Italy; Corresponding author.Fondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, ItalyFondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, ItalyStudio Legale FLC, Rome, ItalyStudio Legale FLC, Rome, ItalyFondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, ItalyFondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, Italy; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, ItalyRegulation (EU) No 536/2014 (Clinical Trial Regulation, CTR) offers two precious tools to academic clinical research in Italy:- The right to transfer not-for-profit clinical trials data and results for registration purposes, and co-sponsorship.- The right to transfer data reduces the time needed to make innovative therapeutical agents and therapies accessible to the patient.Co-sponsorship, on the other hand, allows the establishment of a partnership between entities with different missions, ideals and attitudes, sharing – nevertheless - the same ultimate goal: meeting the patient's medical needs. Co-sponsorship facilitates collaboration among experts, which allows knowledge sharing, thus guaranteeing, to each contributor, recognition for their own contributions to a complex activity such as a clinical trial.However, the above-mentioned Regulation poses important challenges, especially in terms of infrastructural efficiency, which is demanding, especially for those entities suffering organizational inadequacies: unfortunately, inefficiency is sometimes a structural problem in the academic clinical environment. This publication focuses on the specific innovative aspects introduced by CTR. It also highlights the possible difficulties to be addressed by their implementation.http://www.sciencedirect.com/science/article/pii/S2451865422001090Clinical trialsEuropean regulationCo-sponsorshipNot-for-profit clinical trialsAcademic clinical researchLegislation |
spellingShingle | Alessandra Mancino Enrico Crea Monica Messina Marco Ferrante Maria Valeria Feraco Paola Fazi Marco Vignetti Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop Contemporary Clinical Trials Communications Clinical trials European regulation Co-sponsorship Not-for-profit clinical trials Academic clinical research Legislation |
title | Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop |
title_full | Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop |
title_fullStr | Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop |
title_full_unstemmed | Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop |
title_short | Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop |
title_sort | regulation 536 2014 and its beneficial impacts on academic clinical research in italy closing the loop |
topic | Clinical trials European regulation Co-sponsorship Not-for-profit clinical trials Academic clinical research Legislation |
url | http://www.sciencedirect.com/science/article/pii/S2451865422001090 |
work_keys_str_mv | AT alessandramancino regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop AT enricocrea regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop AT monicamessina regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop AT marcoferrante regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop AT mariavaleriaferaco regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop AT paolafazi regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop AT marcovignetti regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop |